Skip to main content

BIOJUME Study Update

By February 26, 2018April 3rd, 2018Research News
Biology of Juvenile Myoclonic Epilepsy

It’s been a great start to the year for our BIOJUME study, with patients now being recruited from 28 UK hospitals. The team will continue to use genetic information from blood tests, combined with EEG data, to investigate the genetic basis of Juvenile Myoclonic Epilepsy (JME) in this international collaboration.

Read more about the BIOJUME study here